In addition to these factors, we found that TGF‐beta‐activated CAFs secrete interleukin‐11 (IL‐11), which leads to enhanced STAT‐3‐dependent survival and initiation of metastatic cancer cells (Calon et al., 2012). Here, TGFB1 is linked to cancer.